CD226 and ovarian carcinoma: Gubbels and colleagues (11) reported that NK cells more effectively eliminate ovarian cancer cells with low csMUC16 expression, which retain activating ligands for DNAM-1 and NKG2D receptors, highlighting MUC16’s critical role in immune escape.